#NeuroscientificBiopharmaceuticals announces #interimCEO #shortvideo #paulrennie #kalkinemedia

preview_player
Показать описание
Neuroscientific Biopharmaceuticals, with the trading code NSB, has announced the appointment of Mr Paul Rennie as Interim CEO, effective immediately. Rennie replaces CEO and Managing Director Matt Liddelow.

Follow us and stay updated on the Go with the Market Charter 👇👇
Рекомендации по теме